What it is

AHK-Cu is a copper-binding tripeptide related to GHK-Cu and listed on skin and recovery research catalogs. Literature and vendor notes position it in matrix and follicle-adjacent research similar to other copper peptides.

It is studied as a distinct sequence from GHK-Cu for comparative copper-peptide work. Left Turn Adventures supplies this compound for laboratory and research use only.

Also known as

AHK-CU · Copper tripeptide AHK · Alanyl-histidyl-lysine copper

Proven benefits

Note: Preclinical / literature endpoints for labs  not established human treatment benefits. Not a protocol.

• Copper-tripeptide matrix and dermal endpoints

• - Hair-follicle and scalp-adjacent markers where studied

• - Wound and remodeling readouts in skin models

• - Comparative copper-peptide pharmacology versus GHK-Cu

• - Antioxidant-adjacent measures in topical/in vitro designs

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

• Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.

• - Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.

• - Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.

• - Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.